Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
  1. 5 Insider Annual Insider Trading Report
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award CEO and President acquired 51,300 shares (grant or award)
  5. 4 Grant or award VP, Controller acquired 5,900 shares (grant or award)
  6. 4 Grant or award Chf Scientific Operations Off acquired 19,900 shares (grant or award)
  7. 4 Grant or award Chief Medical Officer acquired 20,700 shares (grant or award)
  8. 4 Shares withheld for taxes Chf Scientific Operations Off gave up 5,225 shares (to pay taxes)
  9. 4 Shares withheld for taxes CEO and President gave up 5,855 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Medical Officer gave up 1,876 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chf Scientific Operations Off gave up 2,159 shares (to pay taxes)
  12. 4 Shares withheld for taxes CEO and President gave up 6,604 shares (to pay taxes)
  13. 4 Shares withheld for taxes VP, Controller gave up 361 shares (to pay taxes)
  14. 4 Open-market sale 10% owner sold 15,473 shares at $2.71 ($41,949)
  15. 4 Open-market buy 10% owner bought 23,900 shares at an average $3.93 ($93,808)
  16. 4 Open-market buy CEO and President bought 9,065 shares at $3.84 ($34,810)
  17. 4 Shares withheld for taxes Chief Financial Officer gave up 5,081 shares (to pay taxes)
  18. 4 Grant or award VP, Controller acquired 25,000 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Shares withheld for taxes Chief Medical Officer gave up 682 shares (to pay taxes)

Page 6 of 20 · 382 filings